← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Bortezomib currently has availability issues reported in 4 European registers: Spain, Greece, Italy, Sweden.
Shortage ATC L01XG01 · also listed as: BORTEZOMIB · data refreshed 10 September 2026
As of 10 September 2026, 4 of the 9 tracked registers list current availability issues for Bortezomib, covering 9 affected product presentations. The longest-running open report was filed in Spain on 2024-01-31 and has now been open for about 32 months. Where agencies state a cause, delivery delays lead with 2 of the 5 stated-cause reports, followed by manufacturing problems with 1. The furthest expected-resolution date currently on file is 2027-07-27; the earliest is 2026-10-14. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Spain reported first (2024-01-31), with Sweden following roughly 29 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Greece, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Bortezomib is coded L01XG01 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage BORTEZOMIB ACCORD 2,5 MG/ML SOLUCION INYECTABLE, 1 vial de 1 ml + 2 more productsBORTEZOMIB DR. REDDYS 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG, 1 vial BORTEZOMIB WAVERLEY 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG, 1 vial | 2024-01-31 | 2027-07-27 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇬🇷 Greece | Limited availability BORTEZOMIB + 1 more productsBOTEVIA PD.INJ.SOL 3.5MG/VIAL BT x 1 VIAL | 2025-04-09 | 2027-01-26 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευάσματα της Alternatives: Προβλήματα στην παραγωγική | register ↗ |
| 🇮🇹 Italy | Shortage BORTEZOMIB AUROBINDO + 2 more productsBORTEZOMIB DR. REDDY'S BORTEZOMIB MEDAC | 2025-07-10 | — | Elevata richiesta/problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Bortezomib Accord 2,5 mg/ml Injektionsvätska, lösning | 2026-06-20 | 2026-07-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Bortezomib in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | BORTEZOMIB WAVERLEY 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG, 1 vial | Shortage | 2026-08-16 | 2027-07-27 | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | BORTEZOMIB DR. REDDYS 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG, 1 via | Shortage | 2026-06-30 | 2026-10-14 | |
| 🇸🇪 SE | Bortezomib Accord 2,5 mg/ml Injektionsvätska, lösning | Shortage | 2026-06-20 | 2026-07-31 | |
| 🇮🇹 IT | BORTEZOMIB DR. REDDY'S | Shortage | 2026-05-31 | — | Elevata richiesta: forniture discontinue |
| 🇮🇹 IT | BORTEZOMIB AUROBINDO | Shortage | 2026-04-24 | — | Elevata richiesta/problemi produttivi |
| 🇬🇷 GR | BOTEVIA PD.INJ.SOL 3.5MG/VIAL BT x 1 VIAL | Limited availability | 2026-03-12 | 2026-07-31 | Καθυστέρηση παράδοσης περιεκτικότητας TOPOCAN PD.C.SO.IN 4mg |
| 🇮🇹 IT | BORTEZOMIB MEDAC | Shortage | 2025-07-10 | — | Motivi commerciali |
| 🇬🇷 GR | BORTEZOMIB | Limited availability | 2025-04-09 | 2027-01-26 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
| 🇪🇸 ES | BORTEZOMIB ACCORD 2,5 MG/ML SOLUCION INYECTABLE, 1 vial de 1 ml | Shortage | 2024-01-31 | 2026-10-29 | Existen otros medicamentos con el mismo principio activo y m |
Yes. As of 10 September 2026, availability issues are reported in: Spain, Greece, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-14 to 2027-07-27. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
7 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Bortezomib: AEMPS CIMA (Spain), EOF limited-availability list (Greece), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bortezomib — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bortezomib/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bortezomib availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bortezomib/">Bortezomib shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>